Search results
Results from the WOW.Com Content Network
Online, people claim they get brain zaps after stopping use of drugs like Lexapro (escitalopram), Cymbalta (duloxetine), and Paxil (paroxetine), but they can happen when you stop taking any type ...
Changing your dosage or abruptly stopping your medication could cause you to experience antidepressant withdrawal symptoms like those electric shocks — also known as “brain zaps.” Switching ...
Approximately 15–50% of people who suddenly stop an antidepressant develop antidepressant discontinuation syndrome. [ 7 ] [ 2 ] [ 3 ] [ 4 ] The condition is generally not serious, [ 2 ] though about half of people with symptoms describe them as severe. [ 4 ]
If, after a few weeks, it feels like escitalopram isn’t “working,” don’t just stop taking the medication suddenly. Never stop taking the medication or adjust your dosage without speaking ...
Serotonin reuptake inhibitors should not be abruptly discontinued after extended therapy, and whenever possible, should be tapered over several weeks to minimize discontinuation-related symptoms which may include nausea, headache, dizziness, chills, body aches, paresthesias, insomnia, and brain zaps. Paroxetine may produce discontinuation ...
After the last dose has been taken, the acute phase of the withdrawal generally lasts for about two months although withdrawal symptoms, even from low-dose use, can persist for six to twelve months gradually improving over that period, [123] [68] however, clinically significant withdrawal symptoms may persist for years, although gradually ...
Lexapro is an antidepressant that can improve your mood and make symptoms of depression, anxiety, obsessive-compulsive disorder and other mental health issues less severe, helping you to focus on ...
Fluoxetine also has a long half-life which can reduce withdrawal symptoms which are characteristic for some SSRIs after abrupt discontinuation, but it also means that it takes a long time to clear the drug and its active metabolite after discontinuing fluoxetine treatment. [18] Figure 5 Chemical structure of (–)-(3S,4R)-paroxetine